儿童慢性活动性EB病毒感染相关性噬血细胞综合征1例并文献复习
One Case of Chronic Active EB Virus Infection Associated Hemophagocytic Syndrome in Children and Literature Review
DOI: 10.12677/acm.2024.14102690, PDF,   
作者: 张淑红:山东大学附属威海市立医院儿科,山东 威海;刘 霞:山东大学附属威海市立医院影像科,山东 威海
关键词: 慢性活动性EB病毒感染儿童噬血细胞综合征Chronic Active Epstein-Barr Virus Infection Children Hemophagocytic Syndrome
摘要: 目的:总结1例慢性活动性EB病毒感染相关性噬血细胞综合征患儿的临床特点及诊疗经过,提高对该疾病的认识。方法:回顾性分析2022年10月山东大学附属威海市立医院儿科收治的1例慢性活动性EB病毒感染相关性噬血细胞综合征患儿的临床特点及诊疗经过,并进行相关文献复习。结果:患儿以发热、反复肝损害、全血细胞减少、凝血功能紊乱为突出表现,病情发展迅速,短时间内死亡,结合相关检查,诊断为慢性活动性EB病毒感染相关性噬血细胞综合征。结论:对于慢性活动性EB病毒感染患儿,在明确诊断后应积极采取有效治疗措施,一旦引起相关噬血细胞综合征,死亡率极高。
Abstract: Objective: To summarize the clinical characteristics and diagnosis and treatment process of a child with chronic active EB virus infection associated hemophagocytic syndrome, and improve the understanding of this disease. Methods: Retrospective analysis of the clinical characteristics and diagnosis and treatment process of a child with chronic active EB virus infection associated hemophagocytic syndrome admitted to the pediatrics department of Weihai Municipal Hospital affiliated with Shandong University in October 2022, and relevant literature review. Results: The child presented with prominent symptoms such as fever, repeated liver damage, decreased whole blood cells, and coagulation dysfunction. The condition developed rapidly and died within a short period of time. Combined with relevant examinations, the diagnosis was chronic active EB virus infection associated hemophagocytic syndrome. Conclusions: For children with chronic active EB virus infection, effective treatment measures should be actively taken after a clear diagnosis. Once it causes related hemophagocytic syndrome, the mortality rate is extremely high.
文章引用:张淑红, 刘霞. 儿童慢性活动性EB病毒感染相关性噬血细胞综合征1例并文献复习[J]. 临床医学进展, 2024, 14(10): 539-542. https://doi.org/10.12677/acm.2024.14102690

参考文献

[1] 噬血细胞综合征中国专家联盟与中华医学会儿科学分会血液学组. 噬血细胞综合征诊治中国专家共识[J]. 中华医学杂志, 2018, 98(2): 91-95.
[2] Ishii, E., Ohga, S., Imashuku, S., Yasukawa, M., Tsuda, H., Miura, I., et al. (2007) Nationwide Survey of Hemophagocytic Lymphohistiocytosis in Japan. International Journal of Hematology, 86, 58-65. [Google Scholar] [CrossRef] [PubMed]
[3] Ishii, E. (2016) Hemophagocytic Lymphohistiocytosis in Children: Pathogenesis and Treatment. Frontiers in Pediatrics, 4, Article 47. [Google Scholar] [CrossRef] [PubMed]
[4] Swerdlow, S.H., Campo, E., Pileri, S.A., Harris, N.L., Stein, H., Siebert, R., et al. (2016) The 2016 Revision of the World Health Organization Classification of Lymphoid Neoplasms. Blood, 127, 2375-2390. [Google Scholar] [CrossRef] [PubMed]
[5] Sawada, A., Inoue, M. and Kawa, K. (2017) How We Treat Chronic Active Epstein-Barr Virus Infection. International Journal of Hematology, 105, 406-418. [Google Scholar] [CrossRef] [PubMed]
[6] 马遥, 沈燕. 慢性活动性EB病毒感染相关噬血细胞综合征1例并文献复习[J]. 医学检验与临床, 2020, 31(10): 66-68.
[7] 王迁, 王旖旎, 王嫱, 等. 风湿性疾病相关噬血细胞综合征诊疗规范[J]. 中华内科杂志, 2023, 62(1): 23-30.
[8] 徐晓军, 汤永民. 以细胞因子谱指导噬血细胞综合征的精准诊治[J]. 中华医学杂志, 2022, 102(28): 2142-2147.
[9] Yamamoto, M., Sato, M., Onishi, Y., Sasahara, Y., Sano, H., Masuko, M., et al. (2022) Registry Data Analysis of Hematopoietic Stem Cell Transplantation on Systemic Chronic Active Epstein-Barr Virus Infection Patients in Japan. American Journal of Hematology, 97, 780-790. [Google Scholar] [CrossRef] [PubMed]
[10] Bollard, C.M. and Cohen, J.I. (2018) How I Treat T-Cell Chronic Active Epstein-Barr Virus Disease. Blood, 131, 2899-2905. [Google Scholar] [CrossRef] [PubMed]
[11] Liu, P., Pan, X., Chen, C., Niu, T., Shuai, X., Wang, J., et al. (2020) Nivolumab Treatment of Relapsed/Refractory Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in Adults. Blood, 135, 826-833. [Google Scholar] [CrossRef] [PubMed]
[12] Granato, M., Romeo, M.A., Tiano, M.S., Santarelli, R., Gonnella, R., Gilardini Montani, M.S., et al. (2017) Bortezomib Promotes KHSV and EBV Lytic Cycle by Activating JNK and Autophagy. Scientific Reports, 7, Article No. 13052. [Google Scholar] [CrossRef] [PubMed]
[13] Rozman, M., Korać, P., Jambrosic, K. and Židovec Lepej, S. (2022) Progress in Prophylactic and Therapeutic EBV Vaccine Development Based on Molecular Characteristics of EBV Target Antigens. Pathogens, 11, Article 864. [Google Scholar] [CrossRef] [PubMed]